2019nCoVR—A comprehensive genomic resource for SARS-CoV-2 variant surveillance

QR Code

2019nCoVR—A comprehensive genomic resource for SARS-CoV-2 variant surveillance

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Guoqing Lu, Etsuko N. Moriyama
Format:	article
Langue:	EN
Publié:	Elsevier 2021
Sujets:	Science (General) Q1-390
Accès en ligne:	https://doaj.org/article/71a0ccfea09340498eef429569a2b03c
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Mechanism of action of favipiravir against SARS-CoV-2: Mutagenesis or chain termination?
par: Lei Zhao, et autres
Publié: (2021)

Multiplex qPCR discriminates variants of concern to enhance global surveillance of SARS-CoV-2.
par: Chantal B F Vogels, et autres
Publié: (2021)

Insights from Zimbabwe's SARS-CoV-2 genomic surveillance
par: Tafadzwa Dzinamarira, et autres
Publié: (2021)

Data filtering methods for SARS-CoV-2 wastewater surveillance
par: Rezgar Arabzadeh, et autres
Publié: (2021)

Comprehensive literature review on COVID-19 vaccines and role of SARS-CoV-2 variants in the pandemic
par: Charles Yap, et autres
Publié: (2021)

Infecting human hematopoietic stem and progenitor cells with SARS-CoV-2
par: Hector Huerga Encabo, et autres
Publié: (2021)

Isothermal amplification and fluorescent detection of SARS-CoV-2 and SARS-CoV-2 variant virus in nasopharyngeal swabs.
par: Les Jones, et autres
Publié: (2021)

SARS-CoV-2 genomic surveillance in Rondônia, Brazilian Western Amazon
par: Luan Felipo Botelho-Souza, et autres
Publié: (2021)

Point-of-Care Diagnostic Tools for Surveillance of SARS-CoV-2 Infections
par: Dhanasekaran Sakthivel, et autres
Publié: (2021)

SARS-CoV-2 at the human-animal interphase: A review
par: Elmoubasher A. Farag, et autres
Publié: (2021)

Detecting SARS-CoV-2 variants with SNP genotyping.
par: Helen Harper, et autres
Publié: (2021)

Emergence of novel SARS-CoV-2 variants in the Netherlands
par: Aysun Urhan, et autres
Publié: (2021)

The threat of the spread of SARS-CoV-2 variants in animals
par: D. Katterine Bonilla-Aldana, et autres
Publié: (2021)

SARS-CoV-2 sewage surveillance in low-income countries: potential and challenges
par: Juliana Calabria de Araujo, et autres
Publié: (2021)

Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern
par: Donal T. Skelly, et autres
Publié: (2021)

Antibody cocktail effective against variants of SARS-CoV-2
par: Kang-Hao Liang, et autres
Publié: (2021)

SARS-CoV-2 spike protein: Site-specific breakpoints for the development of COVID-19 vaccines
par: Palaniyandi Velusamy, et autres
Publié: (2021)

Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance
par: Stéphane Le Vu, et autres
Publié: (2021)

SARS-CoV-2: fate in water environments and sewage surveillance as an early warning system
par: Deepak Panchal, et autres
Publié: (2021)

Comparison of the Characteristics of Cytokine Storm and Immune Response Induced by SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections
par: Liu T, et autres
Publié: (2021)

Intranasal gene therapy to prevent infection by SARS-CoV-2 variants.
par: Joshua J Sims, et autres
Publié: (2021)

Immune response to SARS-CoV-2 variants of concern in vaccinated individuals
par: Matthias Becker, et autres
Publié: (2021)

The Disease Severity and Clinical Outcomes of the SARS-CoV-2 Variants of Concern
par: Lixin Lin, et autres
Publié: (2021)

SARS-CoV-2 Variants, South Sudan, January–March 2021
par: Daniel Lule Bugembe, et autres
Publié: (2021)

Alpha variant SARS-CoV-2 infection: How it all starts
par: Pere Domingo, et autres
Publié: (2021)

UnCovid: A versatile, low-cost, and open-source protocol for SARS-CoV-2 RNA detection
par: Roberto Alcántara, et autres
Publié: (2021)

Coronavirus (SARS-CoV-2): Preventions, keys to diagnosis and treatment of SARS-CoV-2
par: Kuldeep Singh Patel, et autres
Publié: (2020)

COVseq is a cost-effective workflow for mass-scale SARS-CoV-2 genomic surveillance
par: Michele Simonetti, et autres
Publié: (2021)

Molecular docking and dynamics studies on propolis sulabiroin-A as a potential inhibitor of SARS-CoV-2
par: Jaka Fajar Fatriansyah, et autres
Publié: (2022)

Co-Occurrence of SARS-CoV-2 Infection and Inactivated SARS-CoV-2 Vaccination among Healthcare Workers
par: Cucunawangsih Cucunawangsih, et autres
Publié: (2021)

Testing for SARS-CoV-2
par: Popadić Dušan
Publié: (2021)

SARS-CoV-2 in cardiomyocytes
par: Josef Finsterer
Publié: (2021)

Mouse-adapted SARS-CoV-2 protects animals from lethal SARS-CoV challenge.
par: Antonio Muruato, et autres
Publié: (2021)

Mouse-adapted SARS-CoV-2 protects animals from lethal SARS-CoV challenge
par: Antonio Muruato, et autres
Publié: (2021)

Immune response against SARS-CoV-2 variants: the role of neutralization assays
par: Alicja Maria Chmielewska, et autres
Publié: (2021)

Molecular insights into receptor binding energetics and neutralization of SARS-CoV-2 variants
par: Melanie Koehler, et autres
Publié: (2021)

SARS-CoV-2: Genetic variability, mutations and variants of concern for the global world
par: Ćupić Maja
Publié: (2021)

Molecular and Serological Characterization of the SARS-CoV-2 Delta Variant in Bangladesh in 2021
par: Asish Kumar Ghosh, et autres
Publié: (2021)

SARS-CoV-2 Variants, RBD Mutations, Binding Affinity, and Antibody Escape
par: Lin Yang, et autres
Publié: (2021)

Common Laboratory Mice Are Susceptible to Infection with the SARS-CoV-2 Beta Variant
par: Ravi Kant, et autres
Publié: (2021)